Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase I/II study of human umbilical cord mesenchymal stem cells injection in decompensated hepatitis B cirrhosis
CTR20250073Phase 2Active
- Sponsor
- Tuohua Biotech
- Start
- Mar 2025
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of human umbilical cord mesenchymal stem cells in cirrhosis (LC), sponsored by Tuohua Biotech. Started Mar 2025; status: active.
02
Drugs
human umbilical cord mesenchymal stem cells
03
Conditions
cirrhosis (LC)
Beyond the preview
Go deeper on CTR20250073.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20250073.